AAJ HAS UPDATED ITS PRIVACY POLICY AND USES COOKIES ON THIS SITE. To acknowledge and accept AAJ’s privacy policy with the use of cookies, please select OK, I Accept.

Review AAJ's Privacy Policy
Navy watercolor gradient that gets light from left to right.
Close Alert
Registration is open!

2022 Annual Convention

July 16-19 | Seattle, WA

Build powerful connections and stay ahead of the curve.

Register Today

Litigation Packet

Litigation Packet


UpdatedMar 31, 2015
CreatedMar 25, 2014
Delivery method: Download
  • Risperdal, an atypical (second generation) antipsychotic originally approved for the treatment of schizophrenia and Bipolar I disorder in adults but marketed off-label to children and adolescents, can increased prolactin levels and cause irreversible gynecomastia
  • Includes case screening criteria, a sample complaint, and an overview of litigation
  • Includes pleadings and orders from three mass tort actions in Pennsylvania, New Jersey, and California
  • AAJ Education speaker papers, resources from the U.S. Food and Drug Administration, and a survey of medical journal articles